The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor (vol 72, pg 641, 2007)

被引：0
|
作者：
To, K.
Zhao, Y.
Jiang, H.
Hu, K.
Wang, M.
Wu, J.
Lee, C.
Yokom, D. W.
Stratford, A. L.
Klinge, U.
Mertens, P. R.
Chen, C. S.
Bally, M.
Yapp, D.
Dunn, S. E.
机构：
来源：
MOLECULAR PHARMACOLOGY | 2016年 / 90卷 / 01期
关键词：
D O I：
10.1124/mol.107.036111noticeofconcern
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：61 / 61
页数：1
相关论文
共 3 条
  • [1] The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor (vol 72, pg 641, 2007)
    To, K.
    Zhao, Y.
    Jiang, H.
    Hu, K.
    Wang, M.
    Wu, J.
    Lee, C.
    Yokom, D. W.
    Stratford, A. L.
    Klinge, U.
    Mertens, P. R.
    Chen, C. S.
    Bally, M.
    Yapp, D.
    Dunn, S. E.
    MOLECULAR PHARMACOLOGY, 2014, 85 (03) : 531 - 532
  • [2] The phosphoinositide-dependent kinase-1 inhibitor 2-AminoN-[ 4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1yl] phenyl]-acetamide (OSU-03012) prevents y-box binding protein-1 from inducing epidermal growth factor receptor (Publication with Expression of Concern)
    To, K.
    Zhao, Y.
    Jiang, H.
    Hu, K.
    Wang, M.
    Wu, J.
    Lee, C.
    Yokom, D. W.
    Stratford, A. L.
    Klinge, U.
    Mertens, P. R.
    Chen, C. S.
    Bally, M.
    Yapp, D.
    Dunn, S. E.
    MOLECULAR PHARMACOLOGY, 2007, 72 (03) : 641 - 652
  • [3] 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase
    Porchia, Leonardo M.
    Guerra, Marcy
    Wang, Yu-Chieh
    Zhang, Yunlong
    Espinosa, Allan V.
    Shinohara, Motoo
    Kulp, Samuel K.
    Kirschner, Lawrence S.
    Saji, Motoyasu
    Chen, Ching-Shih
    Ringel, Matthew D.
    MOLECULAR PHARMACOLOGY, 2007, 72 (05) : 1124 - 1131
1